NIB biotec identifies the combination of molecules differently expressed in the urine of healthy subjects and patients with prostate cancer at first diagnosis. They provide ScreeNIB tests, MRI, and invasive tests, such as prostate biopsy services. The ScreeNIB test evaluates the presence of two molecules in the urine and returns a probability ofhaving prostate cancer and therefore the need to carry out more in-depth diagnostic tests.

Health Diagnostics

NIB biotec

NIB biotec's headquarters in Turin, Italy

Description

People (1)

Jobs (0)

Other offices